DZ Bank upgraded AbbVie shares to strong-buy, and Morgan Stanley upgraded the price target on AbbVie stock.

The entities involved

• AbbVie →

  pharmaceutical company

  • MarketBeat's screener has identified a list of dividend stocks.Sun 22:22
  • AbbVie's product portfolio was bolstered by the acquisition of Allergan, while Humira sales faced erosion due to patent loss and biosimilar competition.Sun 13:48
• DZ Bank →

  central institution for around 700 cooperative banks in Germany

  • Rating upgrades and restatements on ASML shares, including an upgrade from hold to strong-buy, were announced.Sun 18:16
• Morgan Stanley →

  U.S. investment bank

  • Financial firms including Morgan Stanley, Truist Financial, Jefferies Financial Group, and CIBC issued rating and price objective updates for Clearway Energy.Mon 17:33
  • Goldman Sachs, Morgan Stanley, JPMorgan Chase, and Bank of America are competing in the global investment banking sector.Mon 17:24

Related events

• DZ Bank raised shares of American Express, which filed reports with the SEC, concurrent with Bank of America increasing its price target.Aug 26
• Bank of America and Norges Bank increased their holdings in AbbVie stock on August 16, 2026.Aug 16
• DZ Bank, Royal Bank of Canada, and Jefferies Financial Group issued rating updates and began coverage on Leonardo stock.Aug 31
• AbbVie is listed on the Nasdaq stock exchange, and MarketBeat is reporting on its stock performance.Sep 4